Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Sars-Cov-2–A Tough Opponent for the Immune System Publisher Pubmed



Nasab MG1, 2 ; Saghazadeh A3, 4 ; Rezaei N4, 5, 6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran
  2. 2. Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tabriz, Iran
  3. 3. Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  4. 4. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran

Source: Archives of Medical Research Published:2020


Abstract

Coronaviruses recently returned with a new one, SARS-CoV-2, related to a potentially severe respiratory disease–called the coronavirus disease (COVID-19). Research shows that the SARS-CoV-2 can be clustered with the Bat SARS-like coronavirus. Bats possess an additional, innate ability for antiviral defense, and, on the other hand, the potential to go hand-in-hand with the virus to generate variability. Besides the high potential of the novel coronavirus in compromising the respiratory system, its rapid transmission and ability to engage many hosts in severe forms of infections or immunopathological complications make it a tough opponent for the immune system. The interactions between SARS-CoV2 and the host immune system result in unleashing tremendous amounts of cytokines, and these cytokines make a storm that would determine the outcome (recovery or death) of the lungs of the patient. © 2020 IMSS
Related Docs
View other Related Docs
1. Th17 and Treg Cells Function in Sars-Cov2 Patients Compared With Healthy Controls, Journal of Cellular Physiology (2021)
2. Immune-Based Therapy for Covid-19, Advances in Experimental Medicine and Biology (2021)
3. The Immune System and Covid-19: Friend or Foe?, Life Sciences (2020)
4. State-Of-The-Art of Nanodiagnostics and Nanotherapeutics Against Sars-Cov-2, ACS Applied Materials and Interfaces (2021)
5. Clinical Characteristics, Laboratory Findings, Radiographic Signs and Outcomes of 61,742 Patients With Confirmed Covid-19 Infection: A Systematic Review and Meta-Analysis, Microbial Pathogenesis (2020)
6. Sars-Cov-2: A Comprehensive Review From Pathogenicity of the Virus to Clinical Consequences, Journal of Medical Virology (2020)
7. The Immune System As a Target for Therapy of Sars-Cov-2: A Systematic Review of the Current Immunotherapies for Covid-19, Life Sciences (2020)
8. Corona Virus Disease 2019 (Covid-19) As a System-Level Infectious Disease With Distinct Sex Disparities, Frontiers in Immunology (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (14)
Mohammadreza Salehi (3)
Other Related Docs
9. Covid-19 and Multiorgan Failure: A Narrative Review on Potential Mechanisms, Journal of Molecular Histology (2020)
10. A Pharmacology-Based Comprehensive Review on Medicinal Plants and Phytoactive Constituents Possibly Effective in the Management of Covid-19, Phytotherapy Research (2021)
11. Clinical Symptoms and Types of Samples Are Critical Factors for the Molecular Diagnosis of Symptomatic Covid-19 Patients: A Systematic Literature Review, International Journal of Microbiology (2021)
12. Covid-19: Review of a 21St Century Pandemic From Etiology to Neuro-Psychiatric Implications, Journal of Alzheimer's Disease (2020)
13. Covid-19: Features, Clinical Course and Concerns, Journal of Cellular and Molecular Anesthesia (2020)
14. Covid-19: General Strategies for Herbal Therapies, Journal of Evidence-Based Integrative Medicine (2022)
15. Variants in Ace2; Potential Influences on Virus Infection and Covid-19 Severity, Infection# Genetics and Evolution (2021)
16. Recent Advances in Antibody-Based Immunotherapy Strategies for Covid-19, Journal of Cellular Biochemistry (2021)
17. Natural Killer Cells in Covid-19: From Infection, to Vaccination and Therapy, Future Virology (2023)
18. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
19. Opioids/Cannabinoids As a Potential Therapeutic Approach in Covid-19 Patients, Expert Review of Respiratory Medicine (2020)
20. The Risk Factors and Clinical Outcomes Associated With Acute Kidney Injury in Patients With Covid-19: Data From a Large Cohort in Iran, Kidney and Blood Pressure Research (2021)
21. Target-Shaped Combined Halo and Reversed-Halo Sign, an Atypical Chest Ct Finding in Covid-19, Clinical Imaging (2021)
22. How Prevalent Is Cancer in Confirmed Cases With Coronaviruses and Severe Acute Respiratory Syndromes?, Advances in Experimental Medicine and Biology (2021)
23. Case Fatality Rate of Covid-19: Meta-Analysis Approach, Archives of Iranian Medicine (2020)
24. Convalescent Plasma Against Covid-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases, Microorganisms (2020)
25. Variable Clinical Manifestations of Covid-19: Viral and Human Genomes Talk, Iranian Journal of Allergy# Asthma and Immunology (2020)
26. Ten Challenging Questions About Sars-Cov-2 and Covid-19, Expert Review of Respiratory Medicine (2020)
27. Naringenin, a Flavanone With Antiviral and Anti-Inflammatory Effects: A Promising Treatment Strategy Against Covid-19, Phytotherapy Research (2020)
28. The Role of Mesenchymal Stromal Cells in Immune Modulation of Covid-19: Focus on Cytokine Storm, Stem Cell Research and Therapy (2020)
29. Nano-Curcumin Therapy, a Promising Method in Modulating Inflammatory Cytokines in Covid-19 Patients, International Immunopharmacology (2020)
30. Management of Environmental Health to Prevent an Outbreak of Covid-19: A Review, Environmental and Health Management of Novel Coronavirus Disease (COVID-19) (2021)
31. Long and Short-Term Metformin Consumption As a Potential Therapy to Prevent Complications of Covid-19, Advanced Pharmaceutical Bulletin (2023)
32. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)
33. Diabetes As One of the Long-Term Covid-19 Complications: From the Potential Reason of More Diabetic Patients’ Susceptibility to Covid-19 to the Possible Caution of Future Global Diabetes Tsunami, Inflammopharmacology (2023)
34. The Role of Mucosal Immunity and Recombinant Probiotics in Sars-Cov2 Vaccine Development, Probiotics and Antimicrobial Proteins (2021)
35. The Importance of Genomic Changes of Sars-Cov-2 and Its Comparison With Iranian-Reported Covid-19 Sequencing; Whether Each Country Has to Design Its Treatment and Vaccine Production, Biomedical and Biotechnology Research Journal (2020)
36. The Role of Emergency Radiology in Covid-19: From Preparedness to Diagnosis, Canadian Association of Radiologists Journal (2020)
37. A Review on an Ongoing Pandemic Caused by the Severe Acute Respiratory Syndrome Coronavirus 2: The Pathogenesis, Epidemiology, Immunological Features, and Currently Available Diagnostic Tests, Reviews and Research in Medical Microbiology (2022)
38. The Association Between Cardiac Injury and Outcomes in Hospitalized Patients With Covid-19, Internal and Emergency Medicine (2020)
39. Pathophysiology of Covid-19 Infection: What Is the Novel Coronavirus (Sars-Cov-2) Doing to Body? a Comprehensive Systematic Review, Reviews and Research in Medical Microbiology (2021)
40. Modern Diagnostics Processes Among New Strains of Coronaviruses: A Review, Journal of Datta Meghe Institute of Medical Sciences University (2022)
41. Extrapulmonary Manifestations of Covid-19: Radiologic and Clinical Overview, Clinical Imaging (2020)
42. Angiotensin-Converting Enzyme 2 (Ace2) Receptor and Sars-Cov-2: Potential Therapeutic Targeting, European Journal of Pharmacology (2020)
43. Point-Of-Use Rapid Detection of Sars-Cov-2: Nanotechnology-Enabled Solutions for the Covid-19 Pandemic, International Journal of Molecular Sciences (2020)
44. Antiviral Optical Techniques As a Possible Novel Approach to Covid-19 Treatment, Journal of Innovative Optical Health Sciences (2021)
45. Covid-19 Infection in Kidney Transplant Recipients From a Single Center in Iran, Experimental and Clinical Transplantation (2022)
46. Mesenchymal Stem Cell Therapies for Covid-19: Current Status and Mechanism of Action, Life Sciences (2020)
47. Nanostructures for Prevention, Diagnosis, and Treatment of Viral Respiratory Infections: From Influenza Virus to Sars-Cov-2 Variants, Journal of Nanobiotechnology (2023)
48. Covid-19: Significance of Antibodies, Human Antibodies (2020)
49. Febuxostat Therapy in Outpatients With Suspected Covid-19: A Clinical Trial, International Journal of Clinical Practice (2020)
50. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)